Skip to main content
VAISHALI · Health Care · 2026-08-07

Vaishali Pharma Ltd

Stage 1 · wk 2In scan: Breakout WatchMARKET: BULL TOPPING · 2026-08-07
₹7.9
-1.25% today
₹103 Cr · Micro cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, anti-pyretic, topical steroids, anti–malarial, cardiac, corticosteroids, anti-diabetics, anti-cold, anti-allergic, anti-diarrheal, anti-protozoal, anti-parasitic, excipients, anti-viral, anti-epileptic, anti-asthmatic, enzymes, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helminitic. The company also provides formulations, including antibiotics, antibacterial, anti-platelet, laxative, anti-ulcer, enzymes, anti-asthmatic, anti-malarial, anti-cold, anti-allergic, anti-viral, anti-psychotic, anti-fungal, vitamins, topical steroids, corticosteroids, anti-inflammatory, analgesic, anti-pyretic, anti-diabetic, cardiac, and other products. In addition, it offers disposable surgical and casting tape products; herbal products; veterinary products; nutraceutical products; and oncology products. The company was formerly known as Vaishali Pharma Private Limited. Vaishali Pharma Limited was founded in 1989 and is based in Mumbai, India.

Visit company website →
P/E (TTM)
119.0
Forward —
Earnings Growth (YoY)
+2.0%
Revenue -11.7%
vs 52W High
-39.2%
₹4.9 lo₹13 hi
39.2% below 52W high — far from high
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 2
1w13w26w
Week 2 — early base, needs time
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
-0.4%
200 DMA: ₹7.9 · sloping down
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.80x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
MA20 gently rising · +1.9% vs MA50 +2.8%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
51.6%
20d Δ
+1.6pp
1M return
+3.1%
3M return
+11.6%
Sector Stage-2 % · last 20 days
Sector has 79 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
→ Flat
Stage 2%
50.5%
20d Δ
+0.5pp
1M return
+1.9%
3M return
+11.7%
Industry Stage-2 % · last 20 days
Industry has 53 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-12 → 2026-08-07
S2 13w
S4 17w
S4 47w
2023-05-122026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 1w → S3 8w → S4 5w → S1 3w → S4 2w → S1 1w → S4 1w → S1 2w → S4 1w → S1 1w → S4 1w → S1 6w → S2 12w → S3 10w → S2 8w → S3 1w → S4 4w → S1 1w → S2 13w → S3 11w → S4 17w → S1 3w → S4 47w → S1 8w → S4 1w → S1 1w current
Total tracked: 168 weeks across 26 stage runs.
1M
+9.4%
3M
+5.5%
6M
-0.9%
YTD
-10.8%
1Y
-36.0%
Scan Membership
Breakout Watch
Latest: 2024-08-21
2 appearances in last 60 days. First seen: 2024-05-16.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-07S1
Wk 2 · Vol x
2026-08-06S1
Wk 1 · Vol x
2026-08-05S1
Wk 1 · Vol x
2026-08-04S1
Wk 1 · Vol x
2026-08-03S1
Wk 1 · Vol x
2026-07-31S14→1
Wk 1 · Vol x
2026-07-30S4
Wk 1 · Vol x
2026-07-29S4
Wk 1 · Vol x
2026-07-28S41→4
Wk 1 · Vol x
2026-07-27S1
Wk 8 · Vol x
2026-07-24S1
Wk 8 · Vol x
2026-07-23S1
Wk 8 · Vol x
Sector Peers — Stage 2All →
DIVISLAB
wk 12 · -3.6% from hi
8.5
LAURUSLABS
wk 16 · -0.3% from hi
8.4
PPLPHARMA
wk 4 · 0.0% from hi
8.2
LALPATHLAB
wk 9 · 0.0% from hi
7.9
SHILPAMED
wk 13 · 0.0% from hi
7.8
Moving averages & range
50 DMA
₹7.5
200 DMA
₹7.9
52W High
₹13
52W Low
₹4.9
5D Low
₹7.6
Resistance levels (recent highs)
20d High
₹8
60d High
₹8
120d High
₹9.1
250d High
₹13
Next resistance
+2.0%
to 20d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.